Northern Trust
ENTX icon

Northern Trust’s Entera Bio ENTX Stock Holding History

Northern Trust’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-146,854
Closed -$163K – 4478
2026
Q1 		$163K Sell
146,854
-1,814
-1% -$2.55K ﹤0.01% 3995
2025
Q4 		$288K Hold
148,668
– – ﹤0.01% 3847
2025
Q3 		$285K Sell
148,668
-52,077
-26% -$99.6K ﹤0.01% 3847
2025
Q2 		$381K Buy
200,745
+1,914
+1% +$3.78K ﹤0.01% 3738
2025
Q1 		$338K Sell
198,831
-13,652
-6% -$29.7K ﹤0.01% 3741
2024
Q4 		$450K Buy
+212,483
New +$397K ﹤0.01% 3698

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Northern Trust's ENTX Position: Q2 2026 in Review

Northern Trust sold out of Entera Bio (ENTX) in Q2 2026, closing a stake of 146,854 shares — an estimated $163K sold.

Northern Trust first reported a position in ENTX in Q4 2024 and held it in 6 quarters. The position peaked at $450K in Q4 2024. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Northern Trust reported no remaining Entera Bio position as of Q2 2026 after selling out during the quarter.
  • Northern Trust sold 146,854 Entera Bio shares in Q2 2026, an estimated $163K.
  • Northern Trust first reported a position in Entera Bio in Q4 2024 and held it in 6 quarters.
  • Northern Trust's Entera Bio position peaked at $450K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.